The objective of the proposed research is to use feline and rat models of the human mucopolysaccharidoses (MRS) to understand the pathogenesis of these disorders, and to develop and evaluate therapeutic strategies for the treatment of their respective human counterparts. This proposal is a continuation of a longstanding collaboration between investigators at the University of Pennsylvania School of Veterinary Medicine and the Mount Sinai School of Medicine. Previously, our laboratories: 1) established breeding colonies for the animal models (cats with MPS I & VI, and rats with MPS VI), 2) characterized the clinical course and pathophysiology of each disease, 3) developed biochemical and molecular detection assays for the lysosomal enzymes which are deficient in these diseases, alpha-L-iduronidase (ID) and 4-sulfatase (4S), 4) isolated and expressed human, feline, and rat 4S and feline ID cDNAs, 5) constructed retroviral and adenoassociated viral vectors encoding human and feline 4S and human ID, 6) evaluated bone marrow transplantation (BMT) in MPS I and VI, 7) performed enzyme replacement therapy trials in MPS I, and 8) initiated hematopoietic progenitor cell gene marking experiments in MPS VI. Recently, we have 1) developed techniques to understand the bone and joint and neuronal pathogenesis, 2) explored protein expression in corneas in MPS I and VI cats, 3) performed neonatal retroviral gene therapy in MPS I and VI cats, and 4) begun enzyme replacement therapy studies with a fusion protein to target the CNS, The specific aims of the current proposal are to: 1) Continue to investigate the pathogenesis of the bone, joint, neuronal, and corneal lesions of MPS I and VI: 2) Continue to evaluate therapy in MPS I and VI using direct injection of modified enzyme into joints and several gene therapy approaches. These animal studies are designed to facilitate our understanding of disease pathogenesis and the development of therapy for the neuronopathic and non-neuronopathic forms of MPS.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-GTIE (01))
Program Officer
Mckeon, Catherine T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pennsylvania
Schools of Veterinary Medicine
United States
Zip Code
Hinderer, Christian; Bell, Peter; Louboutin, Jean-Pierre et al. (2015) Neonatal Systemic AAV Induces Tolerance to CNS Gene Therapy in MPS I Dogs and Nonhuman Primates. Mol Ther 23:1298-1307
Bradbury, Allison M; Gurda, Brittney L; Casal, Margret L et al. (2015) A review of gene therapy in canine and feline models of lysosomal storage disorders. Hum Gene Ther Clin Dev 26:27-37
Hinderer, Christian; Bell, Peter; Gurda, Brittney L et al. (2014) Intrathecal gene therapy corrects CNS pathology in a feline model of mucopolysaccharidosis I. Mol Ther 22:2018-27
Hinderer, Christian; Bell, Peter; Gurda, Brittney L et al. (2014) Liver-directed gene therapy corrects cardiovascular lesions in feline mucopolysaccharidosis type I. Proc Natl Acad Sci U S A 111:14894-9
Simonaro, Calogera M; Sachot, Sylvain; Ge, Yi et al. (2013) Acid ceramidase maintains the chondrogenic phenotype of expanded primary chondrocytes and improves the chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. PLoS One 8:e62715
Ferla, Rita; O'Malley, Thomas; Calcedo, Roberto et al. (2013) Gene therapy for mucopolysaccharidosis type VI is effective in cats without pre-existing immunity to AAV8. Hum Gene Ther 24:163-9
Malik, Saafan Z; Lewis, Melissa; Isaacs, Alison et al. (2012) Identification of the rostral migratory stream in the canine and feline brain. PLoS One 7:e36016
Sewell, Adrian C; Haskins, Mark E; Giger, Urs (2012) Dried blood spots for the enzymatic diagnosis of lysosomal storage diseases in dogs and cats. Vet Clin Pathol 41:548-57
Ponder, Katherine P; O'Malley, Thomas M; Wang, Ping et al. (2012) Neonatal gene therapy with a gamma retroviral vector in mucopolysaccharidosis VI cats. Mol Ther 20:898-907
Sleeper, Meg; Bish, Lawrence T; Haskins, Mark et al. (2011) Status of therapeutic gene transfer to treat cardiovascular disease in dogs and cats. J Vet Cardiol 13:131-40

Showing the most recent 10 out of 71 publications